おすすめの製品
関連するカテゴリー
アプリケーション
Biocompatible, amphiphilic block copolymer composed of a hydrophilic PEG block and a hydrophobic poly(L-lactide) (PLLA) block. These materials have been used in control release and nanoparticle formulation for drug encapsulation and delivery applications. Well-defined materials with varying properties can be prepared by controlling the relative length of each polymer block. Hydroxyl termination allows for facile further chemical modification of these materials.
保管分類コード
11 - Combustible Solids
WGK
WGK 3
引火点(°F)
>230.7 °F
引火点(℃)
> 110.4 °C
最新バージョンのいずれかを選択してください：
Injectable biodegradable polymeric system for preserving the active form and delayed-release of camptothecin anticancer drugs.
Mert O, et al.
Royal Society of Chemistry Advances, 2(1), 176-185 (2012)
Zhigang Xie et al.
Journal of biomedical materials research. Part A, 88(1), 238-245 (2008-02-21)
Docetaxel (DX) is one of the most effective antineoplastic drugs. Its current clinical administration is limited because of its hydrophobicity and serious side effects. A polymer/DX conjugate is designed and successfully prepared to solve these problems. It is monomethoxy-poly(ethylene glycol)-block-poly(L-lactide)/DX
資料
The development of drugs that target specific locations within the human body remains one of the greatest challenges in biomedicine today.
ポリマーソームの合成および、ポリマーソーム標的化を実現するための表面修飾と、薬物放出の制御のための動的または刺激応答性の化学的手段の組込みについて概説します。
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）